Ambev S.A. (ABEV) Stock Price & Analysis
Ambev S.A. (ABEV) closed at USD 3.33 on Thursday, October 22, 2026, up 1.83% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 3.27; the Oct 22, 2026 session ranged USD 3.28–3.34 on volume of 20,768,059 shares. Market capitalization is $51.34B, with a 52-week range of USD 2.18–3.45 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ABEV.md
Key facts (ABEV)
- 3 of 80 tracked superinvestors hold ABEV (13F, Q2 2026): 0 new, 1 added, 2 reduced, 0 unchanged.
- Analysts: Hold (mean 2.91 on a 1–5 scale) (11 analysts), mean target USD 3.35 (range 2.64–4).
- Total return with dividends: 1Y +51.8% vs S&P 500 +14.9%; 5Y +60.6% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0.05, revenue estimate $21.7B.
Superinvestors (SEC 13F-HR, Q2 2026) (ABEV)
3 of 80 tracked investors hold ABEV. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 1.83% | $1.10B | Added +0.7% |
| Richard Pzena | Pzena Investment Management | 0.03% | $11.7M | Reduced -20.7% |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $793K | Reduced -17.5% |
Analysts (ABEV)
Consensus Hold (mean 2.91 on a 1–5 scale), 11 analysts; mean target USD 3.35 (low 2.64, high 4).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | B of A Securities | Downgrade | Neutral → Underperform | $3.3 |
| 2026-07-15 | Scotiabank | Downgrade | Sector Outperform → Sector Perform |
Total return (dividends reinvested) (ABEV)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +51.8% | +60.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +52.0% | +9.9% |
| Volatility (annualized) | 32.0% | 29.4% |
| Max drawdown | -18.7% (May 2026→Aug 2026) | -38.5% (Jun 2023→Dec 2024) |
ABEV analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.05 | $0.05 | -0.3% | $21.67B | 4 |
| Next quarter (ends Dec 2026) | $0.06 | $0.06 | -4.3% | $25.73B | 4 |
| Current fiscal year (ends Dec 2026) | $0.20 | $0.20 | +1.7% | $90.50B | 7 |
| Next fiscal year (ends Dec 2027) | $0.21 | $0.22 | -0.6% | $94.89B | 7 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 3.33 |
|---|---|
| Change | ▲ 1.83% (up) |
| Previous Close | USD 3.27 |
| Open | USD 3.29 |
| Day Range | USD 3.28 – 3.34 |
| 52-Week Range | USD 2.18 – 3.45 |
| Volume | 20,768,059 shares |
| Market Cap | $51.34B |
| Exchange | NYQ |
Technical Analysis (ABEV)
Nexqual's technical model rates ABEV "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.59 (neutral) |
| vs SMA50 | Above (USD 3.02) |
| MACD | 0.09 (positive) |
Analyst Ratings (ABEV)
Wall Street analysts rate ABEV "Hold" based on 11 analysts, with a mean price target of USD 3.35 (range USD 2.64–4), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 3.35 |
| High Target | USD 4 |
| Low Target | USD 2.64 |
| Buy / Hold / Sell | 3 / 5 / 3 |
Earnings (ABEV)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.05 |
| Revenue Estimate | $21.67B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.04 vs est 0.03 ▲ beat |
| 2026-03-31 | USD 0.05 vs est 0.04 ▲ beat |
| 2025-12-31 | USD 0.05 vs est 0.05 ▼ miss |
| 2025-09-30 | USD 0.04 vs est 0.04 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (ABEV)
| Total Revenue | $88.27B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.30% |
| Gross Margin | +51.90% |
| Operating Margin | +23.74% |
| Profit Margin | +18.41% |
| ROE | +18.40% |
| Debt / Equity | 0.03 |
| Current Ratio | 1.02 |
| Total Cash | $18.35B |
| Total Debt | $2.95B |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (ABEV)
Nexqual rates Ambev S.A.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 24% (last 12 months) |
| Balance Sheet | Strong — BRL 18.3B cash vs BRL 2.95B debt, net cash position |
| Cash Flow | Solid — Operating cash flow BRL 28.1B (TTM) |
| Efficiency | Solid — ROE 18%, ROA 10.3% |
Ownership (ABEV)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +7.21% |
| Shares Outstanding | 15.42B |
| Float | 4.05B |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (ABEV)
Ambev S.A. is led by Carlos Eduardo Klutzenschell Lisboa, CEO & Member of Board of Executive Officers, per Nexqual as of October 23, 2026 at 09:25 UTC.
| CEO & Member of Board of Executive Officers | Carlos Eduardo Klutzenschell Lisboa |
|---|---|
| CFO, Investor Relations Officer & Member of the Executive Board | Guilherme Fleury de Figueiredo Ferraz Parolari |
| Legal & Compliance Vice President Officer, Secretary & Member of Executive Board Officers | Guilherme Malik Parente |
| Director of Marketing Transformation | Paula Guz |
| Draftline Media & Data Director | Stella Pescaroli Lopes |
Major Backers & Investors (ABEV)
Notable institutional backers of Ambev S.A. include First Eagle Investment Management, LLC, GQG Partners LLC, ADVISORS' INNER CIRCLE III-GQG PARTNERS EMERGING MARKETS EQUITY FUND, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Eagle Investment Management, LLC | 2.26% |
| GQG Partners LLC | 1.2% |
| ADVISORS' INNER CIRCLE III-GQG PARTNERS EMERGING MARKETS EQUITY FUND | 0.67% |
| Goldman Sachs | 0.19% |
| LOOMIS SAYLES & CO L P | 0.17% |
| Seafarer Capital Partners, LLC | 0.16% |
| Renaissance Technologies | 0.16% |
| Nomura Asset Management International Inc | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.21% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FMX | Fomento Economico Mexicano S.A. | USD 129.03 | ▲ 0.82% |
| STZ | Constellation Brands, Inc. | USD 138.98 | ▲ 5.27% |
| BUD | Anheuser-Busch Inbev SA Sponsor | USD 85.49 | ▲ 3.89% |
| TAP-A | Molson Coors Beverage Company | USD 42.54 | ▼ 8.93% |
| SAM | Boston Beer Company, Inc. (The) | USD 195.72 | ▲ 7.65% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt